| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 10/28/2004 | US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal |
| 10/28/2004 | US20040214862 A N'-hydroxy-terephthalamide derivatives; histone deacetylase enzyme inhibitors; ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS |
| 10/28/2004 | US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 10/28/2004 | US20040214822 Substituted 4-aminocyclohexanol compounds |
| 10/28/2004 | CA2522084A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 10/28/2004 | CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | CA2521487A1 Process and intermediates for the preparation of pyrrolidine carboxylic acids |
| 10/27/2004 | EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 10/27/2004 | EP1470246A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 10/27/2004 | EP1470137A1 Edg receptor agonists |
| 10/27/2004 | EP1470119A1 Benzothiophene compounds having antiinfective activity |
| 10/27/2004 | EP1470106A1 Method of manufacturing an amorphous form of the hemi-calcium salt of (3r, 5r) 7- 3-phenyl-4-phenylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-pyrrol-1-yl!-3, 5-dihydroxyheptanoic acid (atorvastatin) |
| 10/27/2004 | EP1469873A2 Peptidomimetic inhibitors of post-proline cleaving enzymes |
| 10/27/2004 | EP1404687A4 Fluorous triphase and other multiphase systems |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 10/27/2004 | EP1122228B1 Gas-phase dehydration reaction process |
| 10/27/2004 | CN1541200A Hydroxy aromatic mannich base condensation products and use thereof as soot dispersants in lubricating oil compsns. |
| 10/27/2004 | CN1539824A Compounds with analygesic effect |
| 10/27/2004 | CN1539820A Aza aromatic ring substitutional four branched functional molecule material and preparation method |
| 10/27/2004 | CN1172892C Stabilised compositions of 0-and N-vinyl compounds and the use of ammonium salts as stabilisers |
| 10/26/2004 | US6809225 Method for producing 3,3-diarylpropylamines |
| 10/26/2004 | US6809176 Compounds for use in treatment of cancer |
| 10/26/2004 | US6809108 Selective muscarinic m3 receptor antagonts; reduced side effects |
| 10/26/2004 | US6809107 Neurodegenerative diseases |
| 10/26/2004 | US6809093 Drug resistance therapy |
| 10/26/2004 | US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 10/26/2004 | US6809088 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 10/26/2004 | CA2303446C Carbapenem derivatives and a preparation method thereof |
| 10/26/2004 | CA2301818C Bifunctional compounds useful in catalyst reporter deposition |
| 10/26/2004 | CA2181238C Lewis acid catalyzed ammonolysis of nylon |
| 10/21/2004 | WO2004089941A1 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments |
| 10/21/2004 | WO2004089925A1 Pi-3 kinase inhibitor prodrugs |
| 10/21/2004 | WO2004089895A1 Process for the preparation of amorphous calcium salt of atorvastatin |
| 10/21/2004 | WO2004089894A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 10/21/2004 | WO2004089892A2 Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity |
| 10/21/2004 | WO2004089885A1 Novel compounds |
| 10/21/2004 | WO2004089881A1 New sulfonyl derivatives of aminonaphtols |
| 10/21/2004 | WO2004089877A1 New hydroxynaphthyl amides |
| 10/21/2004 | WO2004089362A1 2-cyanopyrroles and their analogues as ddp-iv inhibitors |
| 10/21/2004 | WO2004089360A1 Polyamine compounds for treating chemokine receptor mediated diseases |
| 10/21/2004 | WO2004076407A3 Pyrrolidine derivatives as oxytocin antagonists |
| 10/21/2004 | WO2004043369A3 Sulfonamides |
| 10/21/2004 | US20040210065 Allylmercaptocaptopril compounds and uses thereof |
| 10/21/2004 | US20040209948 especially naphthalene sulfonamides, used for treating asthma |
| 10/21/2004 | US20040209939 Pyrrole derivatives |
| 10/21/2004 | US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 10/21/2004 | US20040209891 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV |
| 10/21/2004 | US20040209863 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents |
| 10/21/2004 | US20040209794 Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds |
| 10/21/2004 | US20040205908 Primary intermediates for oxidative coloration of hair |
| 10/21/2004 | CA2763817A1 Reversible pegylated drugs |
| 10/21/2004 | CA2521903A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 10/21/2004 | CA2521416A1 Polyamine compounds for treating chemokine receptor mediated diseases |
| 10/21/2004 | CA2519157A1 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments |
| 10/21/2004 | CA2518916A1 Pi-3 kinase inhibitor prodrugs |
| 10/20/2004 | EP1468999A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 10/20/2004 | EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 10/20/2004 | EP1467986A1 Aza-cyclic compounds as modulators of acetylcholine receptors |
| 10/20/2004 | EP1467969A2 Dna minor groove binding compounds |
| 10/20/2004 | EP1467727A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 10/20/2004 | EP1467723A1 Phenyl sulfoxides and phenyl sulfones |
| 10/20/2004 | EP1304994B1 Pyrrolyl-substituted nitrophenols used as direct colorants |
| 10/20/2004 | EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 10/20/2004 | EP1263725B1 Novel compounds |
| 10/20/2004 | EP1246619B1 Urotensin-ii receptor antagonists |
| 10/20/2004 | EP1112253B1 Branched alkyl pyrrolidine-3-carboxylic acids |
| 10/20/2004 | CN1538955A Pyrrolidine derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1537899A Water-containing composition comtaining N-alkyltartaric acid imide and N-alkylmaloy |
| 10/20/2004 | CN1171870C Inhibitors of cysteine protease |
| 10/19/2004 | US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 10/19/2004 | US6806286 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 10/19/2004 | US6806264 Arylphenyl-substituted cyclic ketoenols |
| 10/14/2004 | WO2004087940A2 PROCESS FOR PRODUCING ENANTIOPURE β-AMINO ACID DERIVATIVES, AND ENANTIOPURE β-AMINO ACID DERIVATIVES |
| 10/14/2004 | WO2004087695A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 10/14/2004 | WO2004087656A1 Conjugates of 2,4-ethano-bridged and 2,4-propano-bridged 3,6,9-triaza-nonanoic acid, 3n,6n,9,9n-tetraethanoic acid, and corresponding phosphoric acid methylene derivatives and the substitution products thereof with biomolecules, methods for the production thereof, and the use of the same for produ |
| 10/14/2004 | WO2004087638A1 Process for producing amino acid derivatives |
| 10/14/2004 | WO2004087050A2 Mitotic kinesin inhibitors |
| 10/14/2004 | WO2004073585A3 Methode of manufacturing glimepiride and the respective intermediate |
| 10/14/2004 | WO2004056727A3 Process of making chalcone derivatives |
| 10/14/2004 | WO2004032827A3 Hepatitis c virus inhibitors |
| 10/14/2004 | WO2004024939A3 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
| 10/14/2004 | US20040204593 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds |
| 10/14/2004 | US20040204592 Levulinic acid is a well-known product of hexose acid hydrolysis, and can be inexpensively obtained from cellulose feedstocks. |
| 10/14/2004 | US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 10/14/2004 | US20040204590 Ep4 receptor agonist, compositions and methods thereof |
| 10/14/2004 | US20040204476 Oxopyrrolidine compounds, preparations of said compounds and their use in the manufacturing of levetiracetam and analogues |
| 10/14/2004 | US20040204460 Sodium channel modulators |
| 10/14/2004 | US20040204398 Acylated piperazine derivatives as melanocortin-4 receptor agonists |
| 10/14/2004 | US20040204395 Water-soluble drugs and methods for their production |
| 10/14/2004 | US20040204369 Novel amide derivatives |
| 10/14/2004 | US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders |
| 10/14/2004 | DE10315377A1 New carbonyl-substituted carbocyclic or heterocyclic compounds, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or tumors |
| 10/13/2004 | EP1466971A1 Preparation of lactams from aliphatic alpha,omega dinitriles |
| 10/13/2004 | EP1466903A1 Inhibitors of corrosion and of gas hydrates with an improved solubility in water and enhanced biodegradability |
| 10/13/2004 | EP1466902A1 Androgen receptor antagonists |
| 10/13/2004 | EP1466898A1 Beta-amyloid protein production/secretion inhibitors |
| 10/13/2004 | EP1466598A2 PDE-IV inhibitors |
| 10/13/2004 | EP1465901A2 Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hemi-calcium essentially free of organic solvent |
| 10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |